icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI)

Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI)

icon 2020-07-04
عنوان الدراسة
Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI)
داعم الدراسة
KAIMRC
دواء الدراسة
NILOTINIB
رقم بروتوكول الدراسة
RC12/052/R
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)
مرحلة الدراسة
4

Comments and Suggestions

For any inquiries or comments about the government services, please fill in the required information.

Last update date: 01/08/2024 at 02:58 AM Saudi Arabia time